Tandem Diabetes Care, Inc. (TNDM)
Tandem Diabetes Care, Inc. (TNDM) is a healthcare company (medical devices) based in the United States. The share price is $17.06, down 7.68% on the day, which values the company at $1.19B. Price as of 18 Nov 2026, 12:31 UTC, from Yahoo Finance.
Key facts
- Share price
- $17.06−7.68% today
- Market value
- $1.19B
- Forward P/E
- 179.0×
- Funk Score
- 36/100
- Against its own history
- Well below its usual priceusual price $38.13
- 200-week average
- $26.3735% below
- Sector
- Healthcare
Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.
Tandem Diabetes Care, Inc. in more detail
TNDM trades at 179.0× next year's expected earnings, 1.1× sales. Measured against its own history, the price is 55% below what its usual multiples would imply ($38.13) — well below its usual price. It sits 35% below its 200-week average of $26.37.
Over the last five fiscal years Tandem Diabetes Care, Inc. has compounded revenue 15.3% a year. Its Funk Score is 36 out of 100 (financial strength 2.2, profitability 0.2, growth 6.9, value 5.0, each out of 10).
Worth checking: Altman Z in the distress zone; Weak Piotroski score.
Tandem Diabetes Care, Inc. (TNDM): questions and answers
What is Tandem Diabetes Care, Inc.'s market cap?
Tandem Diabetes Care, Inc. is valued at $1.19B at a share price of $17.06.
Is TNDM overvalued or undervalued?
Against its own history, TNDM is well below its usual price: the price is 55% below the $38.13 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.
Is TNDM above its 200-week moving average?
No. TNDM is 35.3% below its 200-week average of $26.37. Long-term investors watch that line because strong companies rarely trade below it for long.
How fast is Tandem Diabetes Care, Inc. growing?
Over the last five fiscal years Tandem Diabetes Care, Inc.'s revenue grew 15.3% a year; over ten years revenue grew 30.1% a year.
Does TNDM pay a dividend?
Tandem Diabetes Care, Inc. does not currently pay a regular dividend.
Learn to read these numbers
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
Cite this page
Funkfolio, “Tandem Diabetes Care, Inc. (TNDM) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/TNDM
Underlying data: Yahoo Finance; company filings with the SEC.